#TalkClinicalTrials: Are we ready to build a system-wide approach to patient engagement in pharmaceutical policy?
In this #TalkClinicalTrials blog, Laurie Proulx & Dawn Richards explore how lived experience must be embedded in pharmaceutical policy—not just as consultation, but as a foundation for decision-making. We live in a time marked by widespread distrust and unpredictability is the norm. Access to medications that help keep people healthy are being scrutinized and difficult […]
AstraZeneca’s $820M Investment Fuels Ontario’s Growth as a Global Life Sciences Leader
#TalkClinicalTrials: A Tale of Two Trials
In this #TalkClinicalTrials blog Munaza Jamil opens up about her mother’s journey through the Canadian healthcare system as a new immigrant, and the urgent need for equitable access to clinical trials. When my mother was diagnosed with end-stage metastatic colorectal cancer, our lives were upended. Her journey—as a woman of color, new immigrant, with limited […]
New Universal Agreement for Clinical Trials Fuels Efficient Start-Up Times in Ontario
Ontario has taken a pioneering step to accelerate the initiation of clinical trials with a new Universal Agreement for Clinical Trials (UACT) for Ontario. Developed by Clinical Trials Ontario (CTO) and the Ontario Leadership Table for Clinical Trials, the UACT is a contract with non-negotiable language that aims to accelerate trial start-up timelines, improve access […]